<code id='5873A96D36'></code><style id='5873A96D36'></style>
    • <acronym id='5873A96D36'></acronym>
      <center id='5873A96D36'><center id='5873A96D36'><tfoot id='5873A96D36'></tfoot></center><abbr id='5873A96D36'><dir id='5873A96D36'><tfoot id='5873A96D36'></tfoot><noframes id='5873A96D36'>

    • <optgroup id='5873A96D36'><strike id='5873A96D36'><sup id='5873A96D36'></sup></strike><code id='5873A96D36'></code></optgroup>
        1. <b id='5873A96D36'><label id='5873A96D36'><select id='5873A96D36'><dt id='5873A96D36'><span id='5873A96D36'></span></dt></select></label></b><u id='5873A96D36'></u>
          <i id='5873A96D36'><strike id='5873A96D36'><tt id='5873A96D36'><pre id='5873A96D36'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:82
          A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT
          A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

          WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Three trends to watch in biotech in 2024
          Three trends to watch in biotech in 2024

          ChristineKao/STATEverywinter,likePunxsutawneynobles,biotech’smanythoughtleadersgatherfortheJ.P.Morga

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Medicare drug price negotiation hasn't dried up venture capital

          AdobeWASHINGTON—VenturecapitalistsarestillpouringmoneyintodrugresearchinspiteofMedicare’snewpowerton